Current and future therapeutic approaches in locally advanced (stage III) non-small cell lung cancer

被引：16

作者：

Davies, A ^{[1
]}

Gandara, DR ^{[1
]}

Lara, P ^{[1
]}

Goldberg, Z ^{[1
]}

Roberts, P ^{[1
]}

Lau, D ^{[1
]}

机构：

[1] Univ Calif Davis, Ctr Canc, Div Hematol Oncol, Sacramento, CA 95817 USA

来源：

SEMINARS IN ONCOLOGY | 2002年 / 29卷 / 03期

关键词：

D O I：

10.1053/sonc.2002.34257

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：10 / 16

页数：7

相关论文

共 33 条

[1]

ALBAIN K, 1999, P AM SOC CLIN ONCOL, V18, pA1162

[2] CONCURRENT CISPLATIN/ETOPOSIDE PLUS CHEST RADIOTHERAPY FOLLOWED BY SURGERY FOR STAGES IIIA(N2) AND IIIB NON-SMALL-CELL LUNG-CANCER - MATURE RESULTS OF SOUTHWEST-ONCOLOGY-GROUP PHASE-II STUDY-8805 [J].

ALBAIN, KS ;

RUSCH, VW ;

CROWLEY, JJ ;

RICE, TW ;

TURRISI, AT ;

WEICK, JK ;

LONCHYNA, VA ;

PRESANT, CA ;

MCKENNA, RJ ;

GANDARA, DR ;

FOSMIRE, H ;

TAYLOR, SA ;

STELZER, KJ ;

BEASLEY, KR ;

LIVINGSTON, RB .

JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (08) :1880-1892

[3]

ALBAIN KS, 1997, P AM SOC CLIN ONCOL, V16, P446

[4] Multiinstitutional phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer [J].

Choy, H ;

Akerley, W ;

Safran, H ;

Graziano, S ;

Chung, C ;

Williams, T ;

Cole, B ;

Kennedy, T .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (10) :3316-3322

[5] A phase II study of paclitaxel, carboplatin, and hyperfractionated radiation therapy for locally advanced inoperable non-small-cell lung cancer (A Vanderbilt cancer center affiliate network study) [J].

Choy, H ;

Devore, RF ;

Hande, KR ;

Porter, LL ;

Rosenblatt, P ;

Yunus, F ;

Schlabach, L ;

Smith, C ;

Shyr, Y ;

Johnson, DH .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 47 (04) :931-937

[6] Radiosensitization with carboplatin for patients with unresectable stage III non-small-cell lung cancer: A phase III trial of the Cancer and Leukemia Group B and the Eastern Cooperative Oncology Group [J].

Clamon, G ;

Herndon, J ;

Cooper, R ;

Chang, AY ;

Rosenman, J ;

Green, MR .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (01) :4-11

[7]

Curran WJ, 2000, P AN M AM SOC CLIN, V19, p484a

[8] Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer [J].

Depierre, A ;

Milleron, B ;

Moro-Sibilot, D ;

Chevret, S ;

Quoix, E ;

Lebeau, B ;

Braun, D ;

Breton, JL ;

Lemarié, E ;

Gouva, S ;

Paillot, N ;

Bréchot, JM ;

Janicot, H ;

Lebas, FX ;

Terrioux, P ;

Clavier, J ;

Foucher, P ;

Monchâtre, M ;

Coëtmeur, D ;

Level, MC ;

Leclerc, P ;

Blanchon, F ;

Rodier, JM ;

Thiberville, L ;

Villeneuve, A ;

Westeel, V ;

Chastang, C .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (01) :247-253

[9] Improved survival in stage III non-small-cell lung cancer: Seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial [J].

Dillman, RO ;

Herndon, J ;

Seagren, SL ;

Eaton, WL ;

Green, MR .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (17) :1210-1215

[10] A RANDOMIZED TRIAL OF INDUCTION CHEMOTHERAPY PLUS HIGH-DOSE RADIATION VERSUS RADIATION ALONE IN STAGE-III NON-SMALL-CELL LUNG-CANCER [J].

DILLMAN, RO ;

SEAGREN, SL ;

PROPERT, KJ ;

GUERRA, J ;

EATON, WL ;

PERRY, MC ;

CAREY, RW ;

FREI, EF ;

GREEN, MR .

NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (14) :940-945

← 1 2 3 4 →